BofA Securities Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Announces Target Price $27

Moomoo NewsOct 18 05:33 ET · Ratings

Zacks.com Featured Highlights Include Barrick Gold, Catalyst Pharmaceuticals, Allegiant Travel and America Movil

Zacks Oct 15 09:35 ET

Unlock Your Portfolio Value With These 4 High Earnings Yield Stocks

Zacks Oct 14 08:30 ET

Capricor Reports Positive Long-term Data for DMD Drug Deramiocel

Seeking AlphaOct 11 12:41 ET

With 75% Ownership of the Shares, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Is Heavily Dominated by Institutional Owners

Yahoo FinanceOct 10 07:23 ET

Catalyst Pharmaceuticals Inc (CPRX) Q2 2024 Earnings Call Highlights: Revenue Surge and ...

InvestingOct 9 11:34 ET